Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma

BMC Cancer. 2005 Aug 23:5:109. doi: 10.1186/1471-2407-5-109.

Abstract

Background: Post-transplant lymphoproliferative disorder (PTLD) is a complication of solid organ and allogeneic hematopoietic stem cell transplantation (HSCT); following autologous HSCT only rare cases of PTLD have been reported. Here, a case of Hodgkin's disease (HD), as unusual presentation of PTLD after autologous HSCT for malignant glioma is described.

Case presentation: 60-years old man affected by cerebral anaplastic astrocytoma underwent subtotal neurosurgical excision and subsequent high-dose chemotherapy followed by autologous HSCT. During the post HSCT course, cranial irradiation and corticosteroids were administered as completion of therapeutic program. At day +105 after HSCT, the patient developed HD, nodular sclerosis type, with polymorphic HD-like skin infiltration.

Conclusion: The clinical and pathological findings were consistent with the diagnosis of PTLD.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Glioma / complications
  • Glioma / therapy*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hodgkin Disease / diagnosis*
  • Humans
  • Lymphatic Metastasis
  • Lymphoproliferative Disorders / etiology*
  • Male
  • Middle Aged
  • Transplantation, Homologous / adverse effects*

Substances

  • Adrenal Cortex Hormones
  • Antineoplastic Agents